NCT07025902

Brief Summary

Postpartum depression (PPD) is one of the most common complications affecting maternal mental health after childbirth, with an estimated prevalence of 10-20% in high-income countries. Despite its frequency and the availability of effective screening tools, early diagnosis remains largely underestimated in routine clinical care. This study, part of the national SOS-Mamma project funded by the Italian Ministry of Health, aims to systematically screen for signs of postpartum depression in women giving birth at a tertiary care obstetric unit (AOU Vanvitelli - UOC of Obstetrics and Gynecology, Naples, Italy). The goal is to promote early detection and timely referral to specialized care pathways. The study is a prospective, observational, monocentric, non-interventional, non-pharmacological study. All eligible women who deliver at the hospital will be invited to participate within the first 72 hours after childbirth. Participants will be asked to complete the Edinburgh Postnatal Depression Scale (EPDS) - a widely used self-report questionnaire - and will undergo a brief clinical interview using the Hamilton Depression Rating Scale (HAM-D), conducted by trained healthcare staff. The study's primary objective is to estimate the real-world incidence of postpartum depression within this population. Secondary objectives include identifying socio-demographic and obstetric risk factors associated with depressive symptoms, assessing the acceptability and feasibility of routine screening, and contributing to the development of a replicable model of care aligned with international recommendations (NICE, WHO, ISS). Collected data will be anonymized and analyzed to provide evidence on early indicators of PPD and guide improvements in clinical care. Women identified as being at risk (e.g., EPDS \>10 or presence of suicidal ideation) will be referred to specialist psychiatric services in accordance with clinical guidelines. Participation in the study is voluntary. All procedures comply with European data protection regulations and Good Clinical Practice (GCP) principles. No experimental treatments are involved, and no changes to standard care will be made based on study participation. By highlighting the need for structured mental health screening in the postpartum period, this study hopes to improve maternal wellbeing and reduce the long-term impact of undiagnosed depression on mothers and their children.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
273

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Jul 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Jul 2025Dec 2027

First Submitted

Initial submission to the registry

June 9, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

12 months

First QC Date

June 9, 2025

Last Update Submit

June 17, 2025

Conditions

Keywords

Post Partum DepressionEPDSHAM-D Scales

Outcome Measures

Primary Outcomes (2)

  • Incidence of postpartum depression assessed by EPDS

    Incidence of postpartum depression assessed by EPDS The proportion of postpartum women who screen positive for depressive symptoms within 72 hours after delivery, based on the Edinburgh Postnatal Depression Scale (EPDS). The EPDS is a 10-item self-report questionnaire, and a score ≥10 is considered indicative of clinically relevant depressive symptoms.

    Within 72 hours postpartum during routine hospital stay following delivery

  • Incidence of postpartum depression assessed by HAM-D

    The proportion of postpartum women who screen positive for depressive symptoms within 72 hours after delivery, based on the Hamilton Depression Rating Scale (HAM-D). This clinician-administered scale assesses severity of depression; established cutoff scores will be used to classify presence of depressive symptoms.

    Within 72 hours postpartum during routine hospital stay following delivery

Study Arms (1)

Postpartum Women Screened Within 72 Hours After Delivery

This cohort consists of postpartum women who deliver a live-born infant at ≥35 weeks of gestation and are clinically stable. Participants are screened within 72 hours after childbirth using the Edinburgh Postnatal Depression Scale (EPDS) and the Hamilton Depression Rating Scale (HAM-D). The study includes both women with and without depressive symptoms, allowing comparison within the cohort based on screening results. The purpose is to assess the incidence of postpartum depression and identify associated socio-demographic or obstetric risk factors in a real-world clinical setting

Diagnostic Test: Standardized Psychological Screening Using EPDS and HAM-D

Interventions

Participants will undergo a standardized psychological screening protocol for postpartum depression within 72 hours after delivery. The protocol includes: (1) completion of the Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-administered questionnaire assessing depressive symptoms; and (2) administration of the Hamilton Depression Rating Scale (HAM-D), a 17-item clinician-administered tool for evaluating the severity of depressive symptoms. The combined use of these tools allows early detection and stratification of postpartum depressive symptoms in a clinical population.

Postpartum Women Screened Within 72 Hours After Delivery

Eligibility Criteria

Age18 Years - 45 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsEligibility is restricted to biological females who have recently delivered a live-born infant. The study targets postpartum women within 72 hours after childbirth in order to assess early depressive symptoms related to the perinatal period. Individuals identifying as women but not having given birth are not eligible. Gender-based eligibility is therefore directly related to the biological and clinical characteristics of postpartum status, which is central to the study objectives.
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The study population consists of postpartum women who deliver at the AOU Vanvitelli - UOC of Obstetrics and Gynecology, a tertiary care academic hospital in Naples, Italy. This is a real-world clinical population composed primarily of women receiving routine obstetric care through the Italian National Health System. The cohort includes patients with both physiological and low-risk obstetric complications. Participants will be recruited during their standard postpartum hospital stay, within 72 hours after delivery.

You may not qualify if:

  • Multiple pregnancy (e.g., twins or higher-order gestations)
  • Major psychiatric diagnosis under active treatment at the time of delivery (e.g., schizophrenia, bipolar disorder)
  • Severe language barriers preventing adequate understanding of the consent form or questionnaires
  • Neonatal death or congenital anomalies requiring prolonged NICU admission
  • Maternal age \<18 or ≥45 years at delivery
  • Gestational age at birth \<35 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Largo Madonna delle grazie 1

Naples, 80138, Italy

Location

Related Publications (1)

  • Luciano M, Di Vincenzo M, Brandi C, Tretola L, Toricco R, Perris F, Volpicelli A, Torella M, La Verde M, Fiorillo A, Sampogna G. Does antenatal depression predict post-partum depression and obstetric complications? Results from a longitudinal, long-term, real-world study. Front Psychiatry. 2022 Dec 14;13:1082762. doi: 10.3389/fpsyt.2022.1082762. eCollection 2022.

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Central Study Contacts

Marco La Verde, MD, researcher, PhD student

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., researcher and PhD student

Study Record Dates

First Submitted

June 9, 2025

First Posted

June 18, 2025

Study Start

July 15, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

June 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared with other researchers. The informed consent form signed by participants does not include provisions for data sharing outside the study team. Additionally, due to the sensitive nature of mental health data and the single-site observational design, sharing of IPD is not planned in order to ensure full compliance with ethical and data protection regulations (including GDPR).

Locations